Tremelimumab and durvalumab with chemotherapy in first-line treatment for metastatic non-small cell lung cancer: a US-based cost-effectiveness analysis
@article{TLCR90623, author = {Ziying Zhao and Xiaohui Zeng and Zhen Zhou and Qiao Liu}, title = {Tremelimumab and durvalumab with chemotherapy in first-line treatment for metastatic non-small cell lung cancer: a US-based cost-effectiveness analysis}, journal = {Translational Lung Cancer Research}, volume = {13}, number = {9}, year = {2024}, keywords = {}, abstract = {}, issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/90623} }